Literature DB >> 15949140

The role of epithelial Toll-like receptor expression in host defense and microbial tolerance.

Mathias W Hornef1, Christian Bogdan.   

Abstract

The recognition of microbial structures by Toll-like receptors (TLRs) on professional immune cells situated at sterile internal body sites occurs during invasive microbial infection. It indicates infectious non-self and thereby represents the adequate co-stimulatory signal to initiate activation of the adaptive immune system against the invading pathogen. In contrast, most epithelial body surfaces are permanently colonized by microbial organisms of the normal flora and thus TLR ligands are present under physiological conditions. In the following, we discuss the characteristics of TLR-mediated recognition by epithelial cells, the subsequent activation of the host immune system, and protective mechanisms that might help to avoid inadequate stimulation and allow differentiation between commensal or pathogenic micro-organisms. Recent findings suggest that the role of epithelial cells in the maintenance of stable microbial colonization of host surfaces and the immediate host response to infectious challenges might have to be revised.

Mesh:

Substances:

Year:  2005        PMID: 15949140     DOI: 10.1179/096805105X35224

Source DB:  PubMed          Journal:  J Endotoxin Res        ISSN: 0968-0519


  16 in total

1.  Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjögren's syndrome.

Authors:  M P Spachidou; E Bourazopoulou; C I Maratheftis; E K Kapsogeorgou; H M Moutsopoulos; A G Tzioufas; M N Manoussakis
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

Review 2.  Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'.

Authors:  Dimitrios Damaskos; George Kolios
Journal:  Br J Clin Pharmacol       Date:  2008-02-12       Impact factor: 4.335

3.  Genetic basis for recurrent vulvo-vaginal candidiasis.

Authors:  Martin Jaeger; Theo S Plantinga; Leo A B Joosten; Bart-Jan Kullberg; Mihai G Netea
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

Review 4.  Epithelial cell innate response to Candida albicans.

Authors:  J R Naglik; D Moyes
Journal:  Adv Dent Res       Date:  2011-04

Review 5.  Candida albicans interactions with epithelial cells and mucosal immunity.

Authors:  Julian R Naglik; David L Moyes; Betty Wächtler; Bernhard Hube
Journal:  Microbes Infect       Date:  2011-07-14       Impact factor: 2.700

6.  Epigenetic Regulation of Tolerance to Toll-Like Receptor Ligands in Alveolar Epithelial Cells.

Authors:  Jacqueline Neagos; Theodore J Standiford; Michael W Newstead; Xianying Zeng; Steven K Huang; Megan N Ballinger
Journal:  Am J Respir Cell Mol Biol       Date:  2015-12       Impact factor: 6.914

7.  Synergism between interleukin (IL)-17 and Toll-like receptor 2 and 4 signals to induce IL-8 expression in cystic fibrosis airway epithelial cells.

Authors:  Shota Mizunoe; Tsuyoshi Shuto; Shingo Suzuki; Chizuru Matsumoto; Kenji Watanabe; Keiko Ueno-Shuto; Mary Ann Suico; Kouhei Onuki; Dieter C Gruenert; Hirofumi Kai
Journal:  J Pharmacol Sci       Date:  2012-03-29       Impact factor: 3.337

Review 8.  Pathogenesis of Helicobacter pylori infection.

Authors:  Johannes G Kusters; Arnoud H M van Vliet; Ernst J Kuipers
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

9.  Differential effects of cytokines and corticosteroids on toll-like receptor 2 expression and activity in human airway epithelia.

Authors:  Audra A Winder; Christine Wohlford-Lenane; Todd E Scheetz; Brie N Nardy; Lori J Manzel; Dwight C Look; Paul B McCray
Journal:  Respir Res       Date:  2009-10-16

10.  New approaches in the development of a vaccine for mucosal candidiasis: progress and challenges.

Authors:  Anna Vecchiarelli; Eva Pericolini; Elena Gabrielli; Donatella Pietrella
Journal:  Front Microbiol       Date:  2012-08-13       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.